BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Argus Health
AstraZeneca
Cerilliant
Accenture
Julphar
Farmers Insurance
Moodys
McKesson

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021744

« Back to Dashboard

NDA 021744 describes PROQUIN XR, which is a drug marketed by Depomed Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug. Additional details are available on the PROQUIN XR profile page.

The generic ingredient in PROQUIN XR is ciprofloxacin hydrochloride. There are thirty-one drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the ciprofloxacin hydrochloride profile page.
Summary for 021744
Tradename:PROQUIN XR
Applicant:Depomed Inc
Ingredient:ciprofloxacin hydrochloride
Patents:4
Formulation / Manufacturing:see details
Pharmacology for NDA: 021744
Ingredient-typeQuinolones
Suppliers and Packaging for NDA: 021744
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROQUIN XR ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021744 NDA Depomed, Inc. 13913-001 13913-001-91 1 BLISTER PACK in 1 CARTON (13913-001-91) > 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
PROQUIN XR ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021744 NDA Depomed, Inc. 13913-001 13913-001-30 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (13913-001-30)

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 500MG BASE
Approval Date:May 19, 2005TE:RLD:No
Patent:➤ SubscribePatent Expiration:Sep 19, 2016Product Flag?YSubstance Flag?Delist Request?
Patented Use:THE TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTIONS
Patent:➤ SubscribePatent Expiration:Sep 19, 2016Product Flag?YSubstance Flag?Delist Request?
Patented Use:THE TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTIONS
Patent:➤ SubscribePatent Expiration:Jun 20, 2020Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 021744

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Depomed Inc PROQUIN XR ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021744-001 May 19, 2005 ➤ Subscribe ➤ Subscribe
Depomed Inc PROQUIN XR ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021744-001 May 19, 2005 ➤ Subscribe ➤ Subscribe
Depomed Inc PROQUIN XR ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021744-001 May 19, 2005 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Healthtrust
Fish and Richardson
Accenture
Farmers Insurance
Fuji
Argus Health
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot